Clinical Trial Update: Acceleration and Relapse Prevention With Triiodothyronine (T3) as an Adjunct to Electroconvulsive Therapy (ECT)

View source ↗

Summary

A completed trial assessed whether adding tri-iodothyronine (T3) to electroconvulsive therapy accelerates antidepressant response. The study also evaluated rela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Triiodothyronine (liothyronine sodium)

Snippet

Sponsor: Mayo Clinic | Conditions: Depression | Status: COMPLETED